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Summary.-Male inbred Fischer rats were fed phenobarbitone-Na at a level of
500 parts/106 in the diet for 1 week, followed by 1000 parts 106 for 103 weeks at which
time the survivors were killed. Thirty-three treated rats survived to 80 weeks.
Before 80 weeks, no animals showed hyperplastic lesions. Of the 33 rats surviving
80 weeks and more, 11 had foci of nodular hyperplasia. These foci were usually small,
but one animal killed at 102 weeks had a lesion of0 75 cm diameter, which compressed
the surrounding liver. In no case was evidence of local invasion or metastasis found.
All the livers had evidence of parenchymal cell damage. No evidence of nodular
hyperplasia was found in the controls.
It is concluded that there is no evidence to suggest that phenobarbitone-Na induced
neoplasm in the liver of male Fischer rats.
PHENOBARBITONE is a drug which is
widely used therapeutically in long-term
treatment. It is also used extensively in
the study of the mechanism of enzyme
induction, and has been shown to modify
the effects of known hepatic carcinogens
in the rat (Peraino et al., 1971). The long-
term administration to mice of 2 strains
demonstrated an increased incidence of
hepatic nodules (Jones and Butler, 1975;
Thorpe and Walker, 1973; Peraino et al.,
1973). In the rat there is less information
on long-term toxicity and while no full
carcinogenicity study has been reported,
Rossi et al. (1977) report the induction of
hepatic nodules, designated as hepatomas.
In this preliminary report, male rats ofa
strain known to be very sensitive to
carcinogens have been fed phenobarbitone
for 2 years.
METHOD
Male inbred Fischer rats from a colony
maintained in the Toxicology Unit, Medical
Research Council Laboratories, Carshalton
were used. Within a week of weaning, from a
group of 75 selected at random, 50 rats were
placed on a diet containing 500 parts/106
phenobarbitone-Na in MRC diet 41B. At the
end ofthe first week, the concentration ofthe
phenobarbitone-Na was increased to 1000
parts/106 in MRC diet 41B, and maintained
at this level for the duration of the experi-
ment. The remaining 25 male rats were
maintained as controls on diet MRC 41B for
2 years. Water was available ad libitum.
Initially the animals were weighed weekly,
during the phase of rapid growth. Subse-
quently, they were weighed at 2-week inter-
vals. Food consumptionwasmeasuredweekly.
Rats were killed when in poor condition
and a complete necropsy examination was
made. Of the animals found dead, 3 were too
autolysed for useful histological study. Tis-
sues from 47 treated and 25 control rats were
examined. These tissues were fixed in formol
saline, and processed into paraffin in the usual
way. Sections were stained with Harris's
haemotoxylin and eosin, and selected sec-
tions were stained by the periodic-acid-Schiff
(PAS) reaction for glycogen and the van
Giesson and Gordon Sweet methods for
collagen and reticulin.
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RESULTS
On examination, the rats on the pheno-
barbitone diet appeared to be less active
than the controls. However, no difference
in the food intake was observed. The
weight gains of the treated and control
groups were similar for the first 6 months.
The mean weight of the controls was then
361 ± 22 g and the treated 367 ± 26-5 g.
At one year, the same groups of rats had
significantly different mean weights of
423 i 26 g for controls and 366 i 30 g
for the treated (P < 0-01). All rats
survived 1 year. Of the treated rats, 17
were killed whenmoribund ordied between
52 and 80 weeks, 21 were killed or died
between 80 and 104 weeks, and 12 were
killed atthetermination oftheexperiment.
Five control rats were killed before 95
weeks, 8 between 95 and 104 weeks, and
12 at the termination of the experiment
at 104 weeks. At necropsy and subsequent
histological examination of the rats killed
or found dead before the termination of
the experiment at 2 years, the animals
had extensive bronchopneumonia and on
occasion pulmonary abscesses. This pat-
tern of respiratory disease is such as one
would expect in the colony, and the
apparent increased severity in the treated
group reflects the continual administra-
tion of a toxic compound. Most of the
early deaths were animals killed in poor
condition to ensure reasonable histology.
Hence the pattern of survival only
roughly reflects the expected natural
mortality.
Macroscopic examination
On no occasion were macroscopic
nodules seen in the liver of either treated
or control animals. In those animals in
which a diagnosis of interstitial tumour
of the testes was made, one or both testes
were irregularly enlarged. The cases of
lymphoreticular neoplasm uniformly pre-
sented with enlarged spleens. In those
FIG. 1.-Liver from a rat treated with phenobarbitone-Na and killed at 102 weeks, showing the edge
of a nodule 0-75 cm in diameter compressing the surrounding liver. There is marked nuclear
pleomorphism within the nodule. Bile proliferation is present in the adjacent liver. H. and E. x 180.
419W. H. BUTLER
cases ofadrenal neoplasm, the adrenal was
enlarged and haemorrhagic.
Histology
Liver.-The first rat to be examined was
killed after 52 weeks on the diet. The liver
showed a normal lobular pattern through-
out, but with marked centrilobular cyto-
megaly of the parenchymal cells. Of the
17 animals examined before 80 weeks, 14
were suitable for histological examina-
tion and showed the same degree of
centrilobular hypertrophy and cyto-
megaly. There was no evidence of focal
parenchymal-cell hyperplasia or signifi-
cant bile-duct hyperplasia. Twenty-one
treated rats died or were killed when in
poor condition between 80 weeks and the
termination of the experiment at 104
weeks. Ofthese, 6 showed focal nodules of
hepatic parenchymal cells. These foci
were usually small, up to 1 mm diam. and
composed ofeither rather small basophilic
cells or much larger vacuolated eosino-
philic cells. One animal killed at 102 weeks
had a lesion 0 75 cm in diameter. This
lesion compressed the surrounding liver,
but no evidence ofinvasion was seen. The
nodule contained portal tracts and was
composed of parenchymal cells with
abundant eosinophilic cytoplasm. The
nuclei were often large and irregular in
shape (Fig. 1). In the remaining liver,
centrilobular cytomegaly was present, as
well as focal areas of fatty degeneration,
and some evidence of cell necrosis. Biliary
proliferation was prominent in all animals.
Associated with most portal tracts, foci
ofsmallbile ducts were seenextendinginto
the surrounding liver. In many cases these
ducts were surrounded by dense fibrous
stroma, whilst in more florid lesions the
epithelial component predominated, mul-
tiple mitotic figures being present (Fig. 2).
Twelve treated rats were killed at the
termination of the experiment at 104
FIG. 2. Liver ofrat treated with phenobarbitone-Na and killed at 100 weeks, showing a large focus of
biliary proliferation with some fibrosis. H. and E. x 200.
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FIG. 3.-Liver of rat treated with phenobarbitone-Na and killed at 104 weeks, showing the edge of a small basophilic nodule. H. and E. x 180.
weeks. Of these, 5 showed small foci of
basophilic parenchymal cells compressing
the surrounding liver (Fig. 3). Mitoses were
present within the foci. Small eosinophilic
foci, comparable to those in the previous
group, were also found. In the remaining
areas of the liver, prominent centrilobular
cytomegaly was seen, as well as diffuse
areas of fatty infiltration and areas of
parenchymal cells with a "ground glass"
appearance. These latter changes did not
distort the lobular pattern of the liver. A
consistent feature of these livers was the
biliary proliferation, which showed the
same variation ofextent as in the animals
killed earlier. No focal nodules or signifi-
cant biliary proliferation were seen in any
of the controls.
Other lesions.-All the animals killed or
found dead before the termination of the
feeding showed varying degrees of bron-
chopneumonia and abscess formation. The
animals killed terminally consistently had
peribronchial cuffing with lymphocytes. These lesions were seen equally in both
treated and control animals. The common-
est neoplasm seen was an interstitial-cell
tumour of the testis. This occurred either
in one or both testes. A total of 19 of the
50 treated and 10 of the 25 control
animals showed this lesion. Histologically,
these showed a consistent pattern, with
associated haemorrhage and necrosis in
the larger tumours. No convincing local
invasion was seen. No metastases were
found. These lesions, considered to be
benign neoplasm, are recognized in this
strain of rat and the incidence is not
modified by the compound.
The other common neoplasm seen was a
lymphoreticular neoplasm, and occurred
in 7 of the treated and 4 of the control
animals. Histologically these appeared as
a rather homogenous group ofneoplasms, best described as lymphosarcoma. These
also are not compound related.
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Other neoplasms recorded arose from
the adrenal gland: 5 treated and 2 control
animals. Two of these were malignant as
diagnosed by the presence of distant
metastases. The origin from cortex or
medulla was in some cases uncertain, but
histologically they appeared to be cortical
neoplasms. A solitary pancreatic islet
adenoma was found in a treated rat killed
at the termination of the experiment.
DISCUSSION
Previously published data on the long-
term effects of phenobarbitone in mice
have given conflicting information on its
carcinogenicity. In the original study of
Thorpe and Walker (1973) a low incidence
ofmetastatichepatocellular carcinomawas
reported in 4/25 male CF1 mice on test.
Also using the CFI mouse, Ponomarkov
et al. (1976) described a high incidence of
hepatocarcinoma, based only on the
presence of local invasion and with no
evidence of metastasis. Peraino et al.
(1973) reported an increased incidence of
"hepatoma", histologically indistinguish-
able from the controls in C3H mice. No
evidence of invasion or metastasis was
reported. In our own series, in which the
lungs of 30 mice with nodular hepatic
lesions have been examined, only 2 cases
ofdistant metastasis have been found. Itis
doubtful from this type of information
whether phenobarbitone should be con-
sidered as a hepatocarcinogen for the
mouse.
No complete carcinogenicity study has
been reported in the rat, although the
results of some long-term feeding studies
are available. The effect of phenobarbi-
tone as an enhancer for hepatocarcino-
genesis has been studied. In the course of
these experiments there have been no
reports ofhepatic carcinoma being directly
attributable to the phenobarbitone
(McLean and Marshall, 1971; Peraino
et al., 1971; Weisburger et al., 1975).
However, Peraino et al. (1975) reported a
single example ofnodular hyperplasia in a
study lasting 450 days, and Rossi et al.
(1977) a 59% incidence of liver-cell
tumours. In the present study, no evi-
dence of focal parenchymal cell hyper-
plasia was found before 80 weeks and, in
the 33 animals examined between that
time and the termination of the experi-
ment at 104 weeks, 11 animals had evi-
dence of focal nodular hyperplasia. In no
animal was there any evidence of hepato-
cellular carcinoma or cholangiocarcinoma,
and there was no evidence for considering
the focal proliferative lesions as benign
neoplasms.
In the animals with hyperplasia there
was consistent evidence of parenchymal-
cell damage, with small areas of necrosis,
fatty infiltration and in some instances
fibrous scarring. All animals examined
after 80 weeks had evidence of biliary
proliferation, which was widespread
throughout the liver, involving most ofthe
portal tracts. However, the extent was
most variable between animals and, at the
most extensive, large areas ofproliferating
small bile ducts were present. These
lesions were only associated with portal
tracts and are considered to be reactive
hyperplasia. Focal biliary cystadenomas
were not seen.
Although this experiment was not
designed as a comprehensive bioassay
carcinogenicity test, and the group size
was small (50), the survival of 66% to
80 weeks and 24% to 2 years is sufficient
to indicate that at the level of 1000 parts/
106 in the diet, phenobarbitone-Na is not a
carcinogen for the male Fischer rat. This
conclusion is supported by the work of
Peraino et al. (1971), Weisburger et al.
(1975) and McLean and Marshall (1971)
and would support the view of Peraino
et al. (1975) that phenobarbitone-Na is not
intrinsically tumorigenic and should be
classified as an enhancer.
This work was supported in part by a grant from
the Cancer Research Campaign.
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